PATH

Grantee website Seattle, Washington, United States
Purpose
to enable testing of double mutant heat-labile toxin of E. coli (dmLT) Inactivated Polio Vaccine in inducing immune responses, which could have important implications in global polio preparedness and eradication
Division
Global Health
Date
NOVEMBER 2016
Region served
GLOBAL
Committed amount
$135,761
Grant topic
Discovery and Translational Sciences
Duration (months)
12
Grantee location
Seattle, Washington, United States

More about our financials

Our story

Learn about the origins of the foundation and the values that drive our work.

Our work

Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.

How we work

We are focused on results. Those that can be measured. And those measured in ways beyond numbers.